Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION TM Analyzer, a highly interactive, fully automated analyzer ...

RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. (OCD) today announced that it obtained Health Canada approval for the ORTHO VISION™ Analyzer, a highly interactive, fully automated ...

The revolutionary ORTHO VISION® analyzer is a highly interactive, fully automated blood bank analyzer engineered for the specific needs of transfusion medicine. Utilizing innovative ID-MTS ® gel ...

Ortho-Clinical Diagnostics, Inc. (OCD) today announced that it obtained CE Mark (Conformité Européenne) for the ORTHO VISION™ Analyzer, a highly interactive, fully automated analyzer for transfusion ...

Please provide your email address to receive an email when new articles are posted on . Ortho Clinical Diagnostics received FDA clearance for Ortho Vision Max, a fully automated blood analyzer ...

RARITAN, N.J., Oct. 18, 2019 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that ORTHO™ Sera, a suite of extended antigen phenotyping, has been ...

RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...

RARITAN, N.J., Nov. 30, 2020 /CNW/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today ...

Ortho-Clinical Diagnostics has signed an exclusive deal worth up to $69 million with commercial-stage company Quotient to distribute and sell a blood transfusion diagnostics platform in development.

RARITAN, N.J., May 3, 2021 /PRNewswire/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...

RARITAN, N.J., July 26, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO ...